Insight Molecular Diagnostics Inc. Common Stock (IMDX)
Since May 17, 2021, Insight Molecular Diagnostics Inc. Common Stock (IMDX) has reported earnings 21 times. On average the shares move ±9.19% post-earnings, with a positive reaction 47.6% of the time. Its largest post-earnings gain was +26.27% (May 13, 2026) and its largest decline was -21.68% (Nov 10, 2022). The next earnings report is predicted for 2026-11-11 (estimated).
Earnings reactions
How IMDX moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±9.19%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 10, 2026 | ☽ POST | -7.28% | open_in_new |
| May 13, 2026 | ☽ POST | +26.27% | open_in_new |
| Mar 26, 2026 | ☽ POST | -13.54% | open_in_new |
| Nov 10, 2025 | ☽ POST | +12.31% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±9.19%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260810 | open_in_new SEC.gov |
| 8-K | 20260810 | open_in_new SEC.gov |
| S-8 | 20260724 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 8-K | 20260617 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
Frequently asked about IMDX earnings
When does Insight Molecular Diagnostics Inc. Common Stock report earnings next? expand_more
Insight Molecular Diagnostics Inc. Common Stock (IMDX)'s next earnings date is estimated for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IMDX stock move after earnings? expand_more
Over 21 reports, IMDX has moved an average of ±9.19% the session after earnings, closing higher 47.6% of the time.
What was IMDX's biggest post-earnings move? expand_more
IMDX's largest post-earnings gain on record was +26.27% on May 13, 2026, and its largest decline was -21.68% on Nov 10, 2022.
Where can I find Insight Molecular Diagnostics Inc. Common Stock's SEC filings? expand_more
All of Insight Molecular Diagnostics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right